Rozzano, 31st January 2024.

Doppel Pharma CDMO is delighted to announce the successful revamping of its Sterile Department (Ampoule) at the Rozzano plant (Milan), culminating in the receipt of AIFA approval in Jan 2024.  In late 2022, Doppel decided to upgrade its Milan based facility to align with stringent Annex 1 GMP Guidelines.

Since then, Doppel collaborated with its customers to ensure continued availability of the injectable products manufactured to patients and hospitals. Activities began in September 2023, with joint efforts across our Quality, Engineering, and Production Departments, resulting in the successful revamping of the department.

The revamped Sterile Department (Ampoule) underscores Doppel Pharma CDMO’s dedication and commitment to maintaining the highest standards in pharmaceutical manufacturing, reaffirming its position as a trusted and reliable partner in the pharmaceutical CDMO landscape.